HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

STAT+: Cell therapy primed liver transplant patients to avoid organ rejection, small study shows

A few transplant patients in a small study were able to stop using immunosuppressive drugs, thanks to pre-transplant cell therapy.

By STAT News · Apr 17, 2026 · via STAT News
STAT+: Cell therapy primed liver transplant patients to avoid organ rejection, small study shows

Image: STAT News

Tags
pipelineformat:headlineheadlineSTAT News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Pipeline
All Pipeline →
Small pools, big ideas: How the rare disease community is reimagining clinical trials
PipelineFierceBiotech ↗
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundre…
Apr 17, 2026
Qiagen launches latest diagnostic for bloodstream infections
PipelineFierceBiotech ↗
Qiagen has moved into syndromic testing for bloodstream infections with the launch of its newest offering.…
Apr 17, 2026
Labcorp launches rapid fentanyl test with 48-hour detection window
PipelineFierceBiotech ↗
While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public healt…
Apr 17, 2026